What matters to life sciences candidates when they are considering job opportunities? BioSpace surveyed our life sciences ...

Sanofi will sell a 50% controlling stake in consumer healthcare unit Opella to private equity firm CD&R, with the French ...

Seaport Therapeutics, kick started by the former leaders of Karuna Therapeutics, has raised a $225 million, oversubscribed ...

In a short statement Friday, Lykos Therapeutics expressed optimism about a recent meeting with the regulator to discuss next ...

United States Pharmacopeia is recruiting expert volunteers from academia, industry, regulatory and healthcare to develop, ...

Novo Nordisk on Monday reported the oral version of its drug semaglutide reduced the risk of major adverse cardiovascular events in adults with type 2 diabetes by 14% in a large Phase III trial.